期刊文献+

014社区60岁以上糖尿病患者应用阿司匹林一级预防心脑血管疾病状况调查 被引量:1

014社区60岁以上糖尿病患者应用阿司匹林一级预防心脑血管疾病状况调查
暂未订购
导出
摘要 目的了解014社区60岁以上未发生心脑血管事件的糖尿病患者,应用阿司匹林的状况。方法2008年6月~2008年7月,在参与体检的014社区60岁以上职工中筛选出糖尿病患者196例,去除已发生心脑血管事件者40例。对156例糖尿病患者进行阿司匹林应用情况调查。结果在156例糖尿病患者中,长期规律应用阿司匹林者56例,占35.9%。其中阿司匹林用量≥75mg/d者39例(25%),阿司匹林用量<75mg/d者17例(10.9%)。未应用阿司匹林者100例(64.1%)。其中不知要应用者69例(44.2%),担心有副作用者24例(15.4%),已出现副作用者7例(0.45%)。156例糖尿病患者中,正确应用阿司匹林者39例,仅占25%。结论阿司匹林在糖尿病患者中一级预防心脑血管疾病应用率远远不足,需在广大医务人员、患者以及全社会进行宣传教育。 Purpose Understand the application condition of aspirin of the diabetic patients (older than 60 years) without heart Cerebrovascular disease. Method From June, 2008 to July, 2008, 196 diabetic patients (older than 60 years) were in the 014 Community. Among them, 40 cases were combined with heart cerebrovascular disease. The application condition of aspirin in the other 156 cases was investigated. Result Among the 156 cases, 56 diabetics (35.9%) are using aspirin regularly; 39(25%) cases were used the aspirin more than 75mg/d and 17 cases (10.9%) were less than 75mg/d. One hundred diabetics (64.1%) never used the aspirin, 69 cases (44.2%) did not know it need to use aspirin; 24 cases (15.4%) were worried about the side-effect and 7 cases (0.45%) occurred the side effect. Only 39 (25%) diabetics used the aspirin correctly among the 156 samples. Conclusion Aspirin was not well used in the diabetics to prevent the heart cerebrovascular disease, this need to be emphasized on doctors, patients and the whole society.
作者 王洛
出处 《当代医学》 2009年第12期134-135,共2页 Contemporary Medicine
关键词 社区 60岁以上 糖尿病患者 阿司匹林 一级预防 心脑血管疾病 Community diabetic over 60 years old aspirin first-grade precaution heart cerebrovascular disease
  • 相关文献

参考文献1

二级参考文献13

  • 1祝之明.搁置争议积极实践:代谢综合征的争议与共识[J].中华医学杂志,2006,86(30):2089-2090. 被引量:8
  • 2吴兆苏.多重心血管病危险综合防治建议[J].中华心血管病杂志,2006,34(12):1061-1071. 被引量:121
  • 3Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 2005, 112(17) : 2735-2752.
  • 4Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation, 2007,115 ( 1 ) : 114- 126.
  • 5Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. Lancet,2005, 366(9497) : 1640-1649.
  • 6Naghavi M, Falk E, Hecht HS, et al. From vulnerable plaque to vulnerable patient--Part Ⅲ: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol , 2006, 98(2A) : 2H-15H.
  • 7Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol, 2007, 27 (1) :15-26.
  • 8Hu DY, Pan CY, Yu JM. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Euro Heart J, 2006, 27(21): 2573-2579.
  • 9Grundy SM. Diabetes and coronary risk equivalency: what does it mean? Diabetes Care, 2006, 29(2) : 457-460.
  • 10Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes ( EASD ). Euro Heart J, 2007, 28(1) : 88-136.

共引文献18

同被引文献5

  • 1Hayden M, Pignone M, Philips C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med, 2002, 136(2): 161- 172.
  • 2US Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med, 2002, 136(2):157-160.
  • 3中华医学会糖尿病分会.中国2型糖尿病防治指南2010.中华内分泌代谢杂志,2011,27(增刊):36.
  • 4孙景金,刘薇薇,俞慧.社区糖尿病患者规范应用阿司匹林情况调查[J].中国社区医师(医学专业),2011,13(6):16-16. 被引量:1
  • 5刘力生.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-708. 被引量:6983

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部